| Public | NASDAQ:SZYM |
| Website | solazyme.com |
| Category | CleanTech |
| Employees | |
| Founded | 2003 |
| Description | Algal-derived Biofuel Producer |
| Total | $146M |
| Series B, 3/07 Roda Group | $10M |
| Debt, 9/07 Bluecrest Capital Finance | $5M |
| Series C, 8/08 Braemar Energy Ventures Lightspeed Venture Partners Harris & Harris Group The Roda Group | $45.4M |
| Series D, 6/09 VantagePoint Capital Partners Braemar Energy Ventures Lightspeed Venture Partners Harris & Harris Group The Roda Group Bunge | $11.6M |
| Grant, 12/09 | $21.8M |
| Series D, 8/10 Braemer Energy Ventures Morgan Stanley Chevron Technology Ventures | $52M |
Solazyme is a synthetic biology company that specializes in converting algal biomass into biofuels. Solazyme not only creates biofuels for the the transportation industry, but is experimenting with ways to tailor its products for the cosmetic and food industries.